Utah’s business landscape is rich with professionals who have le...Read More
Social Media and Employers: Friends or Enemies?
The Case for HSAs
Time to Show Up
Make a Move
In the Lab
Rent to Own
Back from the Dead
A Breath of Fresh Air
Travel & Tourism
Domain Surgical, a medical device company developing advanced thermal surgical technology for soft tissue cutting and coagulation, announced that its FMwand Ferromagnetic Surgical System received the Gold Award in the Surgical Equipment, Instruments and Supplies Category in the 2012 Medical Design Excellence Awards (MDEA) competition. Presented May 23, 2012 at a ceremony in Philadelphia, Pennsylvania, the MDEA is the medical device industry's premier design awards competition and is the only awards program that exclusively recognizes contributions and advances in the design of medical products.
The FMwand surgical system consistently delivers pure thermal energy to cut and coagulate soft tissue and has been used successfully in more than 100 procedures such as the removal of tumors in the brain, spinal cord and liver, lymph node resections, breast surgery, plastic surgery, and others.
Invented by Dr. Kim Manwaring, a board-certified pediatric neurosurgeon, the device consists of a wire loop with a special metallic coating that, when activated, heats instantly. As the heated implement contacts tissue, the device cuts and cauterizes, and when deactivated, cools quickly. The FMwand reduces unintended injury compared to standard monopolar and bipolar electrosurgical instruments or laser devices, and helps contribute to faster healing, fewer unintended burns and less electrical passage into surrounding tissues.
"The development of the FMwand was centered on achieving better tissue effects through advanced instrument design and control of thermal surgical technology,” said David McNally, president and CEO of Domain Surgical. “The remarkable part of this story is how surgeons around the country are embracing the device. In less than five months since the product was introduced, the FMwand has been used in well over 100 surgeries representing a diversity of subspecialties across the United States.”
McNally added that scores of scientists, engineers, doctors, and business partners contributed to the final design of the FMwand. “The creation of the FMwand consisted of thousands of hours of design, experimentation, testing and validation by a truly dedicated team,” McNally said. “The end result is a device that delivers to patients all the benefits of reduced tissue injury, including the potential for faster healing, less scarring and reduced time in surgery.”
Entries for the MDEA competition are evaluated on the basis of their design and engineering features, including innovative use of materials, user-related functions that improve healthcare delivery and change traditional medical attitudes or practices. Also considered are features that provide enhanced benefits to the patient and the ability of the product development team to overcome design and engineering challenges so that the product meets its clinical objectives.
A comprehensive review of the entries was performed by an impartial, multidisciplinary panel of third-party jurors with expertise in biomedical engineering, human factors, industrial design, medicine, and diagnostics.